Front Row Advisors’s CVS Health CVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.5K | Buy |
456
+371
| +436% | +$25.6K | 0.01% | 248 |
|
2025
Q1 | $5.76K | Hold |
85
| – | – | ﹤0.01% | 404 |
|
2024
Q4 | $3.81K | Hold |
85
| – | – | ﹤0.01% | 419 |
|
2024
Q3 | $5.34K | Sell |
85
-270
| -76% | -$17K | ﹤0.01% | 407 |
|
2024
Q2 | $21K | Hold |
355
| – | – | 0.01% | 416 |
|
2024
Q1 | $28.3K | Buy |
355
+150
| +73% | +$12K | 0.01% | 334 |
|
2023
Q4 | $16.2K | Sell |
205
-150
| -42% | -$11.8K | 0.01% | 277 |
|
2023
Q3 | $24.8K | Sell |
355
-247
| -41% | -$17.2K | 0.01% | 335 |
|
2023
Q2 | $42K | Sell |
602
-3
| -0.5% | -$209 | 0.02% | 257 |
|
2023
Q1 | $45K | Sell |
605
-2
| -0.3% | -$149 | 0.02% | 254 |
|
2022
Q4 | $57K | Sell |
607
-4
| -0.7% | -$376 | 0.03% | 227 |
|
2022
Q3 | $58K | Buy |
611
+33
| +6% | +$3.13K | 0.03% | 227 |
|
2022
Q2 | $54K | Buy |
578
+17
| +3% | +$1.59K | 0.03% | 243 |
|
2022
Q1 | $57K | Sell |
561
-9
| -2% | -$914 | 0.02% | 246 |
|
2021
Q4 | $59K | Buy |
570
+205
| +56% | +$21.2K | 0.02% | 251 |
|
2021
Q3 | $31K | Hold |
365
| – | – | 0.01% | 326 |
|
2021
Q2 | $31K | Buy |
365
+33
| +10% | +$2.8K | 0.01% | 333 |
|
2021
Q1 | $25K | Hold |
332
| – | – | 0.01% | 367 |
|
2020
Q4 | $23K | Hold |
332
| – | – | 0.01% | 359 |
|
2020
Q3 | $23K | Buy |
332
+125
| +60% | +$8.66K | 0.01% | 353 |
|
2020
Q2 | $13K | Hold |
207
| – | – | 0.01% | 415 |
|
2020
Q1 | $13K | Sell |
207
-111
| -35% | -$6.97K | 0.01% | 407 |
|
2019
Q4 | $24K | Sell |
318
-2
| -0.6% | -$151 | 0.02% | 300 |
|
2019
Q3 | $20K | Sell |
320
-33
| -9% | -$2.06K | 0.01% | 322 |
|
2019
Q2 | $19K | Hold |
353
| – | – | 0.01% | 327 |
|
2019
Q1 | $19K | Sell |
353
-73
| -17% | -$3.93K | 0.01% | 328 |
|
2018
Q4 | $28K | Buy |
426
+38
| +10% | +$2.5K | 0.02% | 248 |
|
2018
Q3 | $27 | Sell |
388
-1,013
| -72% | -$70 | 0.02% | 264 |
|
2018
Q2 | $92 | Buy |
1,401
+1,085
| +343% | +$71 | 0.06% | 162 |
|
2018
Q1 | $20K | Buy |
316
+68
| +27% | +$4.3K | 0.01% | 328 |
|
2017
Q4 | $18K | Buy |
+248
| New | +$18K | 0.01% | 349 |
|